Lyme disease trials in Canada

1 of 1 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine

  Where

  London, Sherbrooke, Stouffville

  Age

  7 years and over

  People

  1,712 worldwide

  Run by

  Pfizer

  See details and how to joinNCT07500506